companydata.dkcompanydata.dk

IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S: Financial statements 2013

CVR: 16584037

Source: annual report 2013, Danish Business Authority

01/04/2012 – 31/03/2013

IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S (CVR 16584037) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 11,748,880 and a net result of DKK 7,119,974. Equity in the 2013 report amounted to DKK 69,529,409. The solvency ratio was 97.3%.

Gross Profit
DKK 11,748,880
Profit/Loss
DKK 7,119,974
Equity
DKK 69,529,409
Total Assets
DKK 71,485,411

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2013

IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S appoints new auditorJul 19, 2013

As of July 19, 2013, JUT NR. 2180 A/S has been appointed auditor of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.

Auditor steps down at IMMUNODIAGNOSTIC SYSTEMS NORDIC A/SJul 18, 2013

As of July 18, 2013, DANSK REVISION ROSKILDE, GODKENDT REVISIONSAKTIESELSKAB has stepped down as auditor of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.

Christopher Henry Francis Yates joins the board of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/SMar 27, 2013

As of March 27, 2013, Christopher Henry Francis Yates has joined the board of directors of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.

Rudolf Joachim Schemer joins the board of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/SMar 27, 2013

As of March 27, 2013, Rudolf Joachim Schemer has joined the board of directors of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.

Roger Thomas Patrick Duggan leaves the board of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/SMar 27, 2013

As of March 27, 2013, Roger Thomas Patrick Duggan has left the board of directors of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.

Antony William Wilks leaves the board of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/SMar 27, 2013

As of March 27, 2013, Antony William Wilks has left the board of directors of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.

Patrik Olof Dahlén joins IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S as chairmanMar 27, 2013

As of March 27, 2013, Patrik Olof Dahlén is registered as chairman of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.

Rudolf Joachim Schemer joins IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S as adm. dirMar 27, 2013

As of March 27, 2013, Rudolf Joachim Schemer is registered as adm. dir of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.

Paul Hailes steps down as chairman of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/SMar 27, 2013

As of March 27, 2013, Paul Hailes has stepped down as chairman of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.

Roger Thomas Patrick Duggan steps down as direktion of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/SMar 27, 2013

As of March 27, 2013, Roger Thomas Patrick Duggan has stepped down as direktion of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.

About IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S

IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S was a Danish company of the type Aktieselskab based in København S, founded in 1992. The company has been dissolved on 11 October 2019. The company was registered under the industry Engroshandel med kemiske produkter. The company was previously named NORDIC BIOSCIENCE DIAGNOSTICS A/S and OSTEOMETER BIOTECH A/S. The company has 1 employee (2018). In 2019, the company reported a gross profit of DKK 877,018 and a net result of DKK 1,209,814 compared with DKK 5,073,540 the year before. Equity in the 2019 report amounted to DKK 102,384,800.

Source: annual report 2019, Danish Business Authority

Other financial years